BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33903686)

  • 21. Panel-based next-generation sequencing identifies prognostic and actionable genes in childhood acute lymphoblastic leukemia and is suitable for clinical sequencing.
    Ishida H; Iguchi A; Aoe M; Takahashi T; Tamefusa K; Kanamitsu K; Fujiwara K; Washio K; Matsubara T; Tsukahara H; Sanada M; Shimada A
    Ann Hematol; 2019 Mar; 98(3):657-668. PubMed ID: 30446805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genetic background and treatment of pediatric ALL].
    Kato M
    Rinsho Ketsueki; 2018; 59(10):2268-2272. PubMed ID: 30305535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Genetic Variants of IKZF1 Gene Linked with the Growing Risk of Childhood Acute Lymphoblastic Leukaemia.
    Tayel SI; El-Hefnway SM; Abo El-Fotoh WMM; El-Zayat RS
    Curr Mol Med; 2019; 19(1):32-39. PubMed ID: 30806315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency.
    Boutboul D; Kuehn HS; Van de Wyngaert Z; Niemela JE; Callebaut I; Stoddard J; Lenoir C; Barlogis V; Farnarier C; Vely F; Yoshida N; Kojima S; Kanegane H; Hoshino A; Hauck F; Lhermitte L; Asnafi V; Roehrs P; Chen S; Verbsky JW; Calvo KR; Husami A; Zhang K; Roberts J; Amrol D; Sleaseman J; Hsu AP; Holland SM; Marsh R; Fischer A; Fleisher TA; Picard C; Latour S; Rosenzweig SD
    J Clin Invest; 2018 Jul; 128(7):3071-3087. PubMed ID: 29889099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 Gene Polymorphisms to Acute Lymphoblastic Leukemia in a Yemeni Population.
    Al-Absi B; Razif MFM; Noor SM; Saif-Ali R; Aqlan M; Salem SD; Ahmed RH; Muniandy S
    Genet Test Mol Biomarkers; 2017 Oct; 21(10):592-599. PubMed ID: 28768142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adult Low-Hypodiploid Acute B-Lymphoblastic Leukemia With IKZF3 Deletion and TP53 Mutation: Comparison With Pediatric Patients.
    Fang M; Becker PS; Linenberger M; Eaton KD; Appelbaum FR; Dreyer Z; Airewele G; Redell M; Lopez-Terrada D; Patel A; Rabin KR; Lu X
    Am J Clin Pathol; 2015 Aug; 144(2):263-70. PubMed ID: 26185311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel germline TRAF3IP3 mutation in a dyad with familial acute B lymphoblastic leukemia.
    Pommert L; Burns R; Furumo Q; Pulakanti K; Brandt J; Burke MJ; Rao S
    Cancer Rep (Hoboken); 2021 Jun; 4(3):e1335. PubMed ID: 33503336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic abnormalities associated with acute lymphoblastic leukemia.
    Yokota T; Kanakura Y
    Cancer Sci; 2016 Jun; 107(6):721-5. PubMed ID: 26991355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.
    Hof J; Krentz S; van Schewick C; Körner G; Shalapour S; Rhein P; Karawajew L; Ludwig WD; Seeger K; Henze G; von Stackelberg A; Hagemeier C; Eckert C; Kirschner-Schwabe R
    J Clin Oncol; 2011 Aug; 29(23):3185-93. PubMed ID: 21747090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IKZF1 alterations in acute lymphoblastic leukemia: The good, the bad and the ugly.
    Vairy S; Tran TH
    Blood Rev; 2020 Nov; 44():100677. PubMed ID: 32245541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study.
    Michels N; Boer JM; Enshaei A; Sutton R; Heyman M; Ebert S; Fiocco M; de Groot-Kruseman HA; van der Velden VHJ; Barbany G; Escherich G; Vora A; Trahair T; Dalla-Pozza L; Pieters R; Zur Stadt U; Schmiegelow K; Moorman AV; Zwaan CM; den Boer ML
    Lancet Haematol; 2021 Oct; 8(10):e700-e710. PubMed ID: 34560013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism in IKZF1 gene affects age at onset of childhood acute lymphoblastic leukemia.
    Górniak P; Pastorczak A; Zalewska-Szewczyk B; Lejman M; Trelińska J; Chmielewska M; Sokół-Jeżewska A; Kowalczyk J; Szczepanski T; Matysiak M; Kazanowska B; Mlynarski W;
    Leuk Lymphoma; 2014 Sep; 55(9):2174-8. PubMed ID: 24597983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study.
    Yi D; Xu L; Luo J; You X; Huang T; Zi Y; Li X; Wang R; Zhong Z; Tang X; Li A; Shi Y; Rao J; Zhang Y; Sang J
    Hum Genomics; 2019 Jan; 13(1):4. PubMed ID: 30630526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-resolution melting analyses for genetic variants in ARID5B and IKZF1 with childhood acute lymphoblastic leukemia susceptibility loci in Taiwan.
    Lin CY; Li MJ; Chang JG; Liu SC; Weng T; Wu KH; Yang SF; Huang FK; Lo WY; Peng CT
    Blood Cells Mol Dis; 2014; 52(2-3):140-5. PubMed ID: 24200646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TP53 alterations in relapsed childhood acute lymphoblastic leukemia.
    Yu CH; Chang WT; Jou ST; Lin TK; Chang YH; Lin CY; Lin KH; Lu MY; Chen SH; Wu KH; Wang SC; Chang HH; Su YN; Hung CC; Lin DT; Chen HY; Yang YL
    Cancer Sci; 2020 Jan; 111(1):229-238. PubMed ID: 31729120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease.
    Wu J; Wang H; Ricketts CJ; Yang Y; Merino MJ; Zhang H; Shi G; Gan H; Linehan WM; Zhu Y; Ye D
    Cancer; 2019 Apr; 125(7):1060-1069. PubMed ID: 30548481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss-of-function but not dominant-negative intragenic
    Kobitzsch B; Gökbuget N; Schwartz S; Reinhardt R; Brüggemann M; Viardot A; Wäsch R; Starck M; Thiel E; Hoelzer D; Burmeister T
    Haematologica; 2017 Oct; 102(10):1739-1747. PubMed ID: 28751559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ARID5B and IKZF1 variants, selected demographic factors, and childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Linabery AM; Blommer CN; Spector LG; Davies SM; Robison LL; Ross JA
    Leuk Res; 2013 Aug; 37(8):936-42. PubMed ID: 23692655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IKZF1 Gene Deletion in Pediatric Patients Diagnosed with Acute Lymphoblastic Leukemia in Mexico.
    Ayón-Pérez MF; Pimentel-Gutiérrez HJ; Durán-Avelar MJ; Vibanco-Pérez N; Pérez-Peraza VM; Pérez-González ÓA; Barrientos-Ríos R; Santillán-Ávila CF; Zambrano-Zaragoza JF; Agraz-Cibrián JM; Gutiérrez-Franco J; Vázquez-Reyes A
    Cytogenet Genome Res; 2019; 158(1):10-16. PubMed ID: 30974435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia.
    Moorman AV; Schwab C; Ensor HM; Russell LJ; Morrison H; Jones L; Masic D; Patel B; Rowe JM; Tallman M; Goldstone AH; Fielding AK; Harrison CJ
    J Clin Oncol; 2012 Sep; 30(25):3100-8. PubMed ID: 22851563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.